Astellas Pharma (United Kingdom)

Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

Piet Ost, Dries Reynders, Karel Decaestecker et al. · Journal of Clinical Oncology · 2017 · 1.3K citations

Mdt Arm, Urology, Surgical Oncology +12

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide

Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber et al. · Journal of Clinical Oncology · 2017 · 468 citations · Full text

Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference

Pierre Wallemacq, Victor W. Armstrong, Merçè Brunet et al. · Therapeutic Drug Monitoring · 2009 · 453 citations

Uniform Dose, Solid Organ Transplantation, Transplantation Medicine +22

Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID)

Kerrie Davies, Christopher Longshaw, Georgina Davis et al. · The Lancet Infectious Diseases · 2014 · 340 citations

Antibiotics, Clostridium Difficile, Clostridium Difficile Infection +9

A Comparison of the Efficacy and Tolerability of Solifenacin Succinate and Extended Release Tolterodine at Treating Overactive Bladder Syndrome: Results of the STAR Trial

Christopher R. Chapple, R. Martínez-García, Luigi Selvaggi et al. · European Urology · 2005 · 330 citations

Urology, Voiding Dysfunction, Extended Release Tolterodine +6